Tuesday, April 23, 12 PM EDT

Exploring the interface between academia and industry


This is an exciting time in biomedical research. Exome- and genome-wide sequencing studies have provided unprecedented new insights into the molecular—and, specifically, genetic—underpinnings of human disease. For the first time, we are identifying the genes that drive cancer, neurologic disease and many other conditions. Dr. Cigall Kadoch’s research seeks to translate these human genetic discoveries into biochemical mechanisms and new opportunities for therapeutic development.

This webinar will focus on the efforts of Dr. Kadoch and her team on the regulation of our genome’s architecture and how disturbances in this system can cause disease. It also will provide perspectives into how industry and academia can partner in pursuit of innovation and entrepreneurial opportunities.

  • Register for Webinar

Affiliate Faculty of Biological Chemistry and Molecular Biology at Harvard Medical School
Assistant Professor of Pediatric Oncology at the Dana-Farber Cancer Institute
Institute Member and Epigenomics Program Co-Director at the Broad Institute of MIT and Harvard